Pregnant Women Often Not Vaccinated Against Flu
Posted on: Thursday, 20 October 2005, 21:25 CDT
NEW YORK -- Although most obstetricians recommend that their pregnant and breastfeeding patients be immunized against influenza, only about one third offer immunizations within their own practices, new study findings show.
Despite recommendations from the Advisory Committee on Immunization Practices (ACIP) for immunizing pregnant women against influenza, only 13 percent of pregnant women were vaccinated in 2003.
To assess understanding of the ACIP recommendations, the American College of Obstetricians and Gynecologists in May 2004, sent surveys to 1000 ob/gyns regarding their approach to vaccination; 413 responded.
Dr. Kathleen G. Raleigh, an epidemiologist with the CDC, and her colleagues report the survey results in the CDC's Morbidity and Mortality Weekly Report.
Responses showed that 52 percent would recommend influenza vaccination to healthy women in the first trimester if seen in November. Corresponding rates were 95 percent for healthy women in their second and third trimesters, 63 percent for diabetic patients seen in their first trimester, and 63 percent of women breastfeeding a child of 3 months of age.
However, only 36 to 38 percent of those who would recommend vaccination actually offered this service in their own practices.
"Vaccination against influenza is recommended, because women infected with influenza during pregnancy are at increased risk of serious heart and lung conditions that may lead to hospitalizations," Raleigh said in an interview with Reuters Health.
"One study found that out of every 10,000 women in their third trimester during an average flu season, 25 will be hospitalized for flu-related complications," she added. "Inadequate reimbursement, lack of vaccine information for patients, and liability concerns are some of the main barriers to vaccination of pregnant women among providers who did not offer the vaccine."
Also, the survey results showed that very few ob/gyns who see women who appear to have influenza actually confirm the diagnosis with laboratory testing.
"Laboratory diagnosis might help improve identification of influenza at the community level," Raleigh said, "making physicians aware of the presence of influenza in their area and helping them to identify appropriate treatment choices."
SOURCE: Morbidity and Mortality Weekly Report, October 21, 2005.
Source: REUTERS
Related Articles
- Sanofi Pasteur Begins Shipments of Fluzone(R), Influenza Virus Vaccine for 2009-2010 Seasonal Influenza
- Novartis Begins Shipment to US of Fluvirin(R) Influenza Virus Vaccine With Three New Strains for the 2008-2009 Influenza Season
- Vical to Present Phase 1 Data for Vaxfectin(R)-Formulated Pandemic Influenza DNA Vaccines
- Medicago's H5N1 VLP Vaccine Demonstrates Cross-Reactivity Against Multiple Strains of Avian Flu in Key Ferret Animal Model
- Sinovac Commences Vaccination on Volunteers for Phase II Clinical Trial on Pandemic Influenza H5N1 Vaccine
- Sinovac Attended 3rd WHO Meeting on Evaluation of Pandemic Influenza Prototype Vaccines in Clinical Trials
- Thai Gov't to Vaccinate 150,000 Workers Against Influenza
- Chiron Delivers FLUVIRIN(R) Influenza Virus Vaccine to U.S. Customers
- Sanofi Pasteur Donates 200,000 Doses of Fluzone(R), Influenza Virus Vaccine to Support Government's Hurricane Relief Efforts
- FDA On-Site Inspection of Chiron's FLUVIRIN(R) Influenza Virus Vaccine Facility Underway
 |
 |
User Comments (0)
RSS Feeds